标题
Histone Deacetylase Inhibitors as Anticancer Drugs
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 7, Pages 1414
出版商
MDPI AG
发表日期
2017-07-03
DOI
10.3390/ijms18071414
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Epigenetic Therapeutics: A New Weapon in the War Against Cancer
- (2016) Nita Ahuja et al. Annual Review of Medicine
- Valproic Acid Alters Angiogenic and Trophic Gene Expression in Human Prostate Cancer Models
- (2016) RAJU CHELLURI et al. ANTICANCER RESEARCH
- Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
- (2016) Anna Kazanets et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Suberoylanilide hydroxamic acid (SAHA) promotes the epithelial mesenchymal transition of triple negative breast cancer cells via HDAC8/FOXA1 signals
- (2016) Shao Wu et al. BIOLOGICAL CHEMISTRY
- Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
- (2016) Elena Ceccacci et al. BRITISH JOURNAL OF CANCER
- Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway
- (2016) Leopold F. Fröhlich et al. Cancer Cell International
- Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells
- (2016) Taichi Takashina et al. CANCER SCIENCE
- Epigenome-based personalized medicine in human cancer
- (2016) Wenji Yan et al. Epigenomics
- Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
- (2016) Sofia R. Gameiro et al. Oncotarget
- HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
- (2016) Elizabeth E. Hull et al. Biomed Research International
- Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma
- (2016) Mohamed Ashraf Khalil et al. PLoS One
- Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways
- (2015) Jianbin Zhang et al. Autophagy
- The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells
- (2015) Gabriele Greve et al. BMC CANCER
- Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
- (2015) C. M. Adams et al. CANCER RESEARCH
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers
- (2015) Srividya Bhaskara CELL CYCLE
- The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells
- (2015) TOMAS GROH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence
- (2015) Joon-Ho Cho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
- (2015) K.V. Woan et al. Molecular Oncology
- Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat
- (2015) Salma Afifi et al. PHARMACOTHERAPY
- Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail
- (2015) Jutao Feng et al. Cell Adhesion & Migration
- Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites
- (2015) Jessica A. Engel et al. International Journal for Parasitology-Drugs and Drug Resistance
- HDAC inhibitors and immunotherapy; a double edged sword?
- (2015) Michiel Kroesen et al. Oncotarget
- Histone deacetylase inhibitors and cell death
- (2014) Jing Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 – 2013)
- (2014) Sergio Valente et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis
- (2014) Manjola Balliu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs
- (2014) Fengdong Cheng et al. JOURNAL OF IMMUNOLOGY
- Generation of pluripotent stem cells without the use of genetic material
- (2014) Akon Higuchi et al. LABORATORY INVESTIGATION
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights
- (2014) Prithviraj Bose et al. PHARMACOLOGY & THERAPEUTICS
- Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
- (2013) Ming-Tsang Chiao et al. Autophagy
- Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells
- (2013) Hui Yang et al. BIOCHEMICAL PHARMACOLOGY
- Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia
- (2013) I. M. Ghobrial et al. BLOOD
- Histone deacetylase 3 implicated in the pathogenesis of children glioma by promoting glioma cell proliferation and migration
- (2013) Jin Zhu et al. BRAIN RESEARCH
- The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
- (2013) M. A. Salvador et al. CLINICAL CANCER RESEARCH
- Histone deacetylases as targets for treatment of multiple diseases
- (2013) Jinhua Tang et al. CLINICAL SCIENCE
- Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors
- (2013) Madeleine SQ Kortenhorst et al. Epigenetics
- Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF- B-Dependent Autophagy
- (2013) L. Shulak et al. JOURNAL OF VIROLOGY
- Histone deacetylase 10 promotes autophagy-mediated cell survival
- (2013) I. Oehme et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Noncoding RNA and Polycomb recruitment
- (2013) N. Brockdorff RNA
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy
- (2012) K.-T. Lin et al. CLINICAL CANCER RESEARCH
- New Strategies in Acute Myeloid Leukemia: Redefining Prognostic Markers to Guide Therapy
- (2012) I. Khan et al. CLINICAL CANCER RESEARCH
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
- (2012) M. Stiborova et al. CURRENT MEDICINAL CHEMISTRY
- Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8
- (2012) Taeko Wada et al. EMBO REPORTS
- Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
- (2012) Berkley E Gryder et al. Future Medicinal Chemistry
- Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
- (2012) Chung Heon Ryu et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2012) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy
- (2012) Samir E. Witta et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs
- (2012) V. A. Moran et al. NUCLEIC ACIDS RESEARCH
- Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death
- (2012) N. Gammoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
- (2012) Androniki Kretsovali et al. Stem Cells International
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy
- (2011) Min-Yu Chen et al. CANCER
- Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer
- (2011) Victoria L. Luchenko et al. CELL CYCLE
- MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells
- (2011) Patrick Brest et al. ENDOCRINE-RELATED CANCER
- Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors
- (2011) Claudia P. Miller et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The functional role of long non-coding RNA in human carcinomas
- (2011) Ewan A Gibb et al. Molecular Cancer
- Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo
- (2011) G. Dasmahapatra et al. MOLECULAR CANCER THERAPEUTICS
- Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
- (2011) M. Weller et al. NEUROLOGY
- Valproic acid overcomes hypoxia-induced resistance to apoptosis
- (2011) ŠIMON CIPRO et al. ONCOLOGY REPORTS
- Histone Deacetylase Inhibition Enhances Self Renewal and Cardioprotection by Human Cord Blood-Derived CD34+ Cells
- (2011) Ilaria Burba et al. PLoS One
- Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy
- (2011) D. J. Cao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells
- (2010) Jingyi Li et al. Autophagy
- Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
- (2010) Yuan-Ling Liu et al. Autophagy
- Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound -phenylethyl isothiocyanate
- (2010) Y. Hu et al. BLOOD
- The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo
- (2010) G. Dasmahapatra et al. BLOOD
- Vorinostat Plus Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma: A Case Series Illustrating Utility in Clinical Practice
- (2010) Amitabha Mazumder et al. Clinical Lymphoma Myeloma & Leukemia
- Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study
- (2010) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin
- (2010) Akiko Hayashi et al. INTERNATIONAL JOURNAL OF CANCER
- Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
- (2010) Margaret A. Park et al. MOLECULAR CANCER THERAPEUTICS
- Highly Compacted Chromatin Formed In Vitro Reflects the Dynamics of Transcription Activation In Vivo
- (2010) Guohong Li et al. MOLECULAR CELL
- Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents
- (2010) M. Namdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia
- (2009) Kristie A. Blum et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antitumor Effects of a Combined 5-Aza-2'Deoxycytidine and Valproic Acid Treatment on Rhabdomyosarcoma and Medulloblastoma in Ptch Mutant Mice
- (2009) I. Ecke et al. CANCER RESEARCH
- Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
- (2009) A. Badros et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors
- (2009) Xujun Ma et al. DRUGS
- Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer
- (2009) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
- (2009) E J Noonan et al. ONCOGENE
- Synergistic effect of trichostatin A and 5-aza-2′-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: A proteomic study
- (2009) Daniela Cecconi et al. PROTEOMICS
- Inhibition of histone deacetylase1 induces autophagy
- (2008) Meeyeon Oh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
- Acetylation Is Indispensable for p53 Activation
- (2008) Yi Tang et al. CELL
- Promoter hypomethylation regulates CD133 expression in human gliomas
- (2008) Kouichi Tabu et al. CELL RESEARCH
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors
- (2008) Simone Fulda CURRENT CANCER DRUG TARGETS
- Acetylation of non-histone proteins modulates cellular signalling at multiple levels
- (2008) Stephanie Spange et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice
- (2008) Rusty L. Montgomery et al. JOURNAL OF CLINICAL INVESTIGATION
- SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway
- (2008) A Hrzenjak et al. JOURNAL OF PATHOLOGY
- Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
- (2008) Xiang-Jiao Yang et al. MOLECULAR CELL
- Sirtuins — novel therapeutic targets to treat age-associated diseases
- (2008) Siva Lavu et al. NATURE REVIEWS DRUG DISCOVERY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- HDAC Inhibitors Act with 5-aza-2′-Deoxycytidine to Inhibit Cell Proliferation by Suppressing Removal of Incorporated Abases in Lung Cancer Cells
- (2008) Guolin Chai et al. PLoS One
- A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
- (2008) I. H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes
- (2008) Elizabeth A. Griffiths et al. SEMINARS IN HEMATOLOGY
- Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells
- (2007) Shan Gao et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More